II. Definitions
- Atrial Tachycardia
- Form of Paroxysmal Supraventricular Tachycardia (10% of cases) with increased automaticity
III. Epidemiology
- Least common Supraventricular Tachycardia (10% of cases, less common than AVNRT, AVRT)
- Most often in otherwise healthy young adults
IV. Pathophysiology
V. Findings: Electrocardiogram
-
Heart Rate 130 to 180 (up to 250 bpm)
- Contrast with Atrial Flutter (250 to 350 bpm)
- At least one atrial beat for every ventricular beat
- However atrial beats may exceed ventricular beats (e.g. 1:1 or 1:4 AV conduction)
- Similar to Atrial Flutter, but Atrial Tachycardia rates are slower (<250 bpm)
- May occur in repetitive short bursts of Atrial Tachycardia
- P Wave morphology varies by atrial focus and is best visualized in leads V1 and II
- PR Interval is normal
- RP Interval is longer than PR Interval
- When due to increased automaticity
- Rate typically ramps up over a 5 to 10 second period before reaching a more constant Tachycardia
- In contrast, microreentry mechanisms start and stop abruptly
- Contrast with Sinus Tachycardia which ramps up more slowly and responds to physiologic measures (e.g. IV fluids)
VI. Types
- Atrial Tachycardia
- Focal
- Microreentry
- Multifocal Atrial Tachycardia
- Irregular narrow complex rhythm with 3 or more different P Wave morphologies
VII. Causes: Multifocal Atrial Tachycardia
- Causes: Enlarged atrium
- Chronic lung disease
- Congestive Heart Failure
- Causes: Other
- Acid-base disturbance
- Electrolyte abnormalities
VIII. Management: Focal Atrial Tachycardia
- Catheter Ablation Indications
- Recurrent Focal Atrial Tachycardia
- Secondary Cardiomyopathy due to Atrial Tachycardia
- Medical Management
- Beta Blocker (e.g. Metoprolol)
- Nondihydropyridine Calcium Channel Blocker (e.g. Diltiazem)
- Contraindicated in Congestive Heart Failure
- Antiarrhythmics (Propafenone, Flecainide)
- Indicated in ischemic or structural heart disease